(NYSE: CBT) Cabot's forecast annual revenue growth rate of 1.42% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.4%.
Cabot's revenue in 2026 is $3,713,000,000.On average, 6 Wall Street analysts forecast CBT's revenue for 2026 to be $191,493,569,120, with the lowest CBT revenue forecast at $180,966,712,696, and the highest CBT revenue forecast at $204,030,579,032. On average, 6 Wall Street analysts forecast CBT's revenue for 2027 to be $196,995,041,824, with the lowest CBT revenue forecast at $186,626,881,728, and the highest CBT revenue forecast at $209,003,063,976.
In 2028, CBT is forecast to generate $205,617,542,312 in revenue, with the lowest revenue forecast at $197,418,232,032 and the highest revenue forecast at $217,837,159,568.